Magnesium status and the metabolic syndrome: A systematic review and meta-analysis

Nutrition

Volumn 32, Issue 4, 2016, Pages 409-417

  Sarrafzadegan, Nizal ^a   Khosravi Boroujeni, Hossein ^a,b   Lotfizadeh, Masoud ^c   Pourmogaddas, Ali ^d   Salehi Abargouei, Amin ^e  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GRIFFITH UNIVERSITY   (Australia)

^c SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus; Dietary magnesium; Metabolic syndrome; Serum magnesium

Indexed keywords

MAGNESIUM;

BODY MASS; DIABETES MELLITUS; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; HUMAN; MAGNESIUM BLOOD LEVEL; MAGNESIUM INTAKE; METABOLIC SYNDROME X; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; BLOOD; META ANALYSIS; OBSERVATIONAL STUDY; RISK FACTOR;

HUMANS; MAGNESIUM; METABOLIC SYNDROME X; OBSERVATIONAL STUDIES AS TOPIC; RISK FACTORS;

EID: 84959047701     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2015.09.014     Document Type: Review

References (69)

1. Cameron A.J., Shaw J.E., Zimmet P.Z. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004, 33:351-375.
2. Appels C.W., Vandenbroucke J.P. Overweight, obesity, and mortality. N Engl J Med 2006, 355:2699.
3. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
4. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005, 28:1769-1778.
5. Khosravi-Boroujeni H., Sarrafzadegan N., Mohammadifard N., Alikhasi H., Sajjadi F., Asgari S., et al. Consumption of sugar-sweetened beverages in relation to the metabolic syndrome among Iranian adults. Obes Facts 2012, 5:527-537.
6. Saris N.E., Mervaala E., Karppanen H., Khawaja J.A., Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 2000, 294:1-26.
7. Lopez Martinez J., Sanchez Castilla M., Garcia de Lorenzo y Mateos A., Culebras Fernandez J.M. Nutr Hosp 1997, 12:4-14.
8. Barbagallo M., Dominguez L.J., Galioto A., Ferlisi A., Cani C., Malfa L., et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 2003, 24:39-52.
9. Elin R.J. Magnesium metabolism in health and disease. Dis Mon 1988, 34:161-218.
10. de Lordes Lima M., Cruz T., Pousada J.C., Rodrigues L.E., Barbosa K., Cangucu V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 1998, 21:682-686.
11. Song Y., Li T.Y., van Dam R.M., Manson J.E., Hu F.B. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 2007, 85:1068-1074.
12. Guerrero-Romero F., Rodriguez-Moran M. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. J Hum Hypertens 2009, 23:245-251.
13. Altura B.M., Altura B.T. Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res 1995, 41:347-359.
14. Rasmussen H.S., Aurup P., Goldstein K., McNair P., Mortensen P.B., Larsen O.G., et al. Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study. Arch Intern Med 1989, 149:1050-1053.
15. Nadler J.L., Buchanan T., Natarajan R., Antonipillai I., Bergman R., Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993, 21:1024-1029.
16. Guerrero-Romero F., Tamez-Perez H.E., Gonzalez-Gonzalez G., Salinas-Martinez A.M., Montes-Villarreal J., Trevino-Ortiz J.H., et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabete Metab 2004, 30:253-258.
17. Rodriguez-Moran M., Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003, 26:1147-1152.
18. McCarty M.F. Magnesium may mediate the favorable impact of whole grains on insulin sensitivity by acting as a mild calcium antagonist. Med Hypotheses 2005, 64:619-627.
19. Song Y., Manson J.E., Buring J.E., Liu S. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 2004, 27:59-65.
20. Guerrero-Romero F., Rodriguez-Moran M. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab Res Rev 2006, 22:471-476.
21. Abbott R.D., Ando F., Masaki K.H., Tung K.H., Rodriguez B.L., Petrovitch H., et al. Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu Heart Program). Am J Cardiol 2003, 92:665-669.
22. Huang J.H., Lu Y.F., Cheng F.C., Lee J.N., Tsai L.C. Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: a cross-sectional study. Nutr J 2012, 11:41.
23. Bo S., Durazzo M., Guidi S., Carello M., Sacerdote C., Silli B., et al. Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort. Am J Clin Nutr 2006, 84:1062-1069.
24. Ju S.Y., Choi W.S., Ock S.M., Kim C.M., Kim D.H. Dietary magnesium intake and metabolic syndrome in the adult population: dose-response meta-analysis and meta-regression. Nutrients 2014, 6:6005-6019.
25. Dibaba D.T., Xun P., Fly A.D., Yokota K., He K. Dietary magnesium intake and risk of metabolic syndrome: a meta-analysis. Diabet Med 2014, 31:1301-1309.
26. Guerrero-Romero F., Rodriguez-Moran M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002, 39:209-213.
27. Yu Y., Cai Z., Zheng J., Chen J., Zhang X., Huang X.F., et al. Serum levels of polyunsaturated fatty acids are low in Chinese men with metabolic syndrome, whereas serum levels of saturated fatty acids, zinc, and magnesium are high. Nutr Res 2012, 32:71-77.
28. Simmons D., Joshi S., Shaw J. Hypomagnesaemia is associated with diabetes: not pre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract 2010, 87:261-266.
29. Kauffman R.P., Tullar P.E., Nipp R.D., Castracane V.D. Serum magnesium concentrations and metabolic variables in polycystic ovary syndrome. Acta Obstet Gynecol Scand 2011, 90:452-458.
30. Guo H., Lee J.D., Guo M., Lu Y., Tang F., Ueda T. Status of intracellular and extracellular magnesium concentration in patients with cardiac syndrome X. Acta Cardiol 2005, 60:259-263.
31. Aguilar M.V., Saavedra P., Arrieta F.J., Mateos C.J., Gonzalez M.J., Meseguer I., et al. Plasma mineral content in type-2 diabetic patients and their association with the metabolic syndrome. Ann Nutr Metab 2007, 51:402-406.
32. Corica F., Corsonello A., Ientile R., Cucinotta D., Di Benedetto A., Perticone F., et al. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr 2006, 25:210-215.
33. Xu J., Xu W., Yao H., Sun W., Zhou Q., Cai L. Associations of serum and urinary magnesium with the pre-diabetes, diabetes and diabetic complications in the Chinese Northeast population. PLoS One 2013, 8:e56750.
34. Roislien J., Van Calster B., Hjelmesaeth J. Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study. Cardiovasc Diabetol 2011, 10:17.
35. Beydoun M.A., Gary T.L., Caballero B.H., Lawrence R.S., Cheskin L.J., Wang Y. Ethnic differences in dairy and related nutrient consumption among US adults and their association with obesity, central obesity, and the metabolic syndrome. Am J Clin Nutr 2008, 87:1914-1925.
36. Kalaitzidis R., Tsimihodimos V., Bairaktari E., Siamopoulos K.C., Elisaf M. Disturbances of phosphate metabolism: another feature of metabolic syndrome. Am J Kidney Dis 2005, 45:851-858.
37. Egger M., Smith G.D., Altman D.G. Systematic reviews in health care: meta-analysis in context 2001, BMJ, London. 2nd ed.
38. Song Y., Ridker P.M., Manson J.E., Cook N.R., Buring J.E., Liu S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2005, 28:1438-1444.
39. Evangelopoulos A.A., Vallianou N.G., Panagiotakos D.B., Georgiou A., Zacharias G.A., Alevra A.N., et al. An inverse relationship between cumulating components of the metabolic syndrome and serum magnesium levels. Nutr Res 2008, 28:659-663.
40. Ghasemi A., Zahediasl S., Syedmoradi L., Azizi F. Low serum magnesium levels in elderly subjects with metabolic syndrome. Biol Trace Elem Res 2010, 136:18-25.
41. Lima Mde L., Cruz T., Rodrigues L.E., Bomfim O., Melo J., Correia R., et al. Serum and intracellular magnesium deficiency in patients with metabolic syndrome-evidences for its relation to insulin resistance. Diabetes Res Clin Pract 2009, 83:257-262.
42. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
43. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
44. American Diabetes Association Nutrition recommendations and principles for people with diabetes mellitus. Tenn Med 2000, 93:430-433.
45. Ford E.S., Li C., McGuire L.C., Mokdad A.H., Liu S. Intake of dietary magnesium and the prevalence of the metabolic syndrome among U.S. adults. Obesity 2007, 15:1139-1146.
46. He K., Liu K., Daviglus M.L., Morris S.J., Loria C.M., Van Horn L., et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 2006, 113:1675-1682.
47. He K., Song Y., Belin R.J., Chen Y. Magnesium intake and the metabolic syndrome: epidemiologic evidence to date. J Cardiometab Syndr 2006, 1:351-355.
48. Kandeel F.R., Balon E., Scott S., Nadler J.L. Magnesium deficiency and glucose metabolism in rat adipocytes. Metab Clin Exp 1996, 45:838-843.
49. Kass L., Weekes J., Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr 2012, 66:411-418.
50. McKeown N.M., Jacques P.F., Zhang X.L., Juan W., Sahyoun N.R. Dietary magnesium intake is related to metabolic syndrome in older Americans. Eur J Nutr 2008, 47:210-216.
51. Noori N., Nafar M., Poorrezagholi F., Ahmadpoor P., Samadian F., Firouzan A., et al. Dietary intakes of fiber and magnesium and incidence of metabolic syndrome in first year after renal transplantation. J Ren Nutr 2010, 20:101-111.
52. Paolisso G., Sgambato S., Gambardella A., Pizza G., Tesauro P., Varricchio M., et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr 1992, 55:1161-1167.
53. Rayssiguier Y., Noe L., Etienne J., Gueux E., Cardot P., Mazur A. Effect of magnesium deficiency on post-heparin lipase activity and tissue lipoprotein lipase in the rat. Lipids 1991, 26:182-186.
54. Morrell J.S., Lofgren I.E., Burke J.D., Reilly R.A. Metabolic syndrome, obesity, and related risk factors among college men and women. J Am Coll Health 2012, 60:82-89.
55. Mirmiran P., Shab-Bidar S., Hosseini-Esfahani F., Asghari G., Hosseinpour-Niazi S., Azizi F. Magnesium intake and prevalence of metabolic syndrome in adults: Tehran Lipid and Glucose Study. Public Health Nutr 2012, 15:693-701.
56. Choi M.K., Bae Y.J. Relationship between dietary magnesium, manganese, and copper and metabolic syndrome risk in Korean adults: The Korea National Health and Nutrition Examination Survey (2007-2008). Biol Trace Elem Res 2013, 156:56-66.
57. Al-Daghri N.M., Khan N., Alkharfy K.M., Al-Attas O.S., Alokail M.S., Alfawaz H.A., et al. Selected dietary nutrients and the prevalence of metabolic syndrome in adult males and females in Saudi Arabia: a pilot study. Nutrients 2013, 5:4587-4604.
58. Song Y., He K., Levitan E.B., Manson J.E., Liu S. Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med 2006, 23:1050-1056.
59. Elin R.J. Assessment of magnesium status for diagnosis and therapy. Magnes Res 2010, 23:S194-S198.
60. Topf J.M., Murray P.T. Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disord 2003, 4:195-206.
61. Bardicef M., Bardicef O., Sorokin Y., Altura B.M., Altura B.T., Cotton D.B., et al. Extracellular and intracellular magnesium depletion in pregnancy and gestational diabetes. Am J Obstet Gynecol 1995, 172:1009-1013.
62. Jahnen-Dechent W., Ketteler M. Magnesium basics. Clin Kidney J 2012, 5:i3-i14.
63. Corica F., Allegra A., Ientile R., Buemi M., Corsonello A., Bonanzinga S., et al. Changes in plasma, erythrocyte, and platelet magnesium levels in normotensive and hypertensive obese subjects during oral glucose tolerance test. Am J Hypertens 1999, 12:128-136.
64. Altura B.T., Brust M., Bloom S., Barbour R.L., Stempak J.G., Altura B.M. Magnesium dietary intake modulates blood lipid levels and atherogenesis. Proc Natl Acad Sci U S A 1990, 87:1840-1844.
65. Paolisso G., Ravussin E. Intracellular magnesium and insulin resistance: results in Pima Indians and Caucasians. J Clin Endocrinol Metab 1995, 80:1382-1385.
66. Touyz R.M. Role of magnesium in the pathogenesis of hypertension. Mol Aspects Med 2003, 24:107-136.
67. Takaya J., Higashino H., Kobayashi Y. Intracellular magnesium and insulin resistance. Magnes Res 2004, 17:126-136.
68. Laughlin M.R., Thompson D. The regulatory role for magnesium in glycolytic flux of the human erythrocyte. J Biol Chem 1996, 271:28977-28983.
69. Itoh K., Kawasaka T., Nakamura M. The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br J Nutr 1997, 78:737-750.